PRESS RELEASE: Paid Content from Business Wire. The AP news staff was not involved in its creation.

Old Man, 75 - Rejuvenates His Telomeres to the Equivalent of a 10-Year-Old — Extended Longevity Demonstrates Conclusive Proof

 
Share

MAUI, Hawaii--(BUSINESS WIRE)--Jul 5, 2022--

Extended Longevity, a Hawaii-based longevity company focused on reversing the biomarkers of aging, announces that new test results show the regrowth of telomeres in a 75 year old man to the equivalent of a 10 year old (a 65 year reversal), using the SpectraCell Laboratories Telomere test. Thus, this demonstrates that his aging process, as represented by telomere biomarker tests, has significantly regenerated. https://www.extendedlongevity.com/lab-results

“Our test subject, one of many to experience this amazing rejuvenation technology, is a 75-year-old man who has regrown his telomeres to 9,300 base pairs; this is a remarkable achievement in the longevity sciences,” said Steven M. Schorr, Founder and CEO. Telomeres are the end caps of chromosomes and protect them from unraveling, much like the plastic tip of a shoelace. Each time the cell divides the telomeres gets shorter until it is no longer capable of dividing. It then becomes senescent and increases inflammation in the body, the causes of the diseases of aging. To regrow the telomeres means the cells remain youthful and productive.

Extended Longevity has introduced a product line of ten targeted phytotherapeutic formulations that have demonstrated significant success in decelerating the 10 determinant factors of aging. The company is currently running medically supervised studies, with independent lab tests revealing that these formulations have regrown telomeres to lengths consistent with preteens, significantly lowered levels of inflammation, and rolled back the epigenetic clock by an astonishing 15 years, in a cohort of people ages 42 to 75. Available on the Extended Longevity website are case studies detailing before and after results of a small test cohort.

Additionally, the Company has launched a crowdfunding offering on Wefunder, with perks that reward the investor with sets of the Extended Longevity Protocol. You can learn about our offering here: https://wefunder.com/extended.longevity.inc

The field of longevity science is the next great leap in human biology, and Extended Longevity boasts a patent-pending solution with proven scientific results. This test demonstrates conclusively the power of this life-extending protocol.

CEO Steven Schorr is an entrepreneur and executive with 47 years of experience. He is a patented inventor and scientist dedicated to creating data-driven products for the health and wellness industry.

Disclosures:

We are ‘testing the waters’ to gauge investor interest in an offering under Regulation Crowdfunding. No money or other consideration is being solicited. If sent, it will not be accepted. No offer to buy securities will be accepted. No part of the purchase price will be received until a Form C is filed and only through Wefunder’s platform. Any indication of interest involves no obligation or commitment of any kind.

View source version on businesswire.com:https://www.businesswire.com/news/home/20220705005028/en/

CONTACT: Extended Longevity

Steven M. Schorr, 844-420-0193

[email protected]

KEYWORD: HAWAII UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE SENIORS RESEARCH GENERAL HEALTH HEALTH VITAMINS/SUPPLEMENTS CONSUMER

SOURCE: Extended Longevity

Copyright Business Wire 2022.

PUB: 07/05/2022 10:11 AM/DISC: 07/05/2022 10:12 AM

http://www.businesswire.com/news/home/20220705005028/en